Related Experiment Videos
Antiphospholipid syndrome.
1Medical Center for Rheumatology, Berlin, Germany. gromnica-ihle@berlin.snafu.de
International Archives of Allergy and Immunology
|October 3, 2000
Summary
Antiphospholipid syndrome (APS) is an autoimmune disorder causing blood clots and pregnancy loss, diagnosed by antiphospholipid antibodies (aPL). It can be primary or secondary to other conditions like lupus erythematosus (SLE).
Area of Science:
- Autoimmune diseases
- Hematology
- Reproductive immunology
Background:
- Antiphospholipid syndrome (APS) is a significant autoimmune disorder.
- It is characterized by recurrent thrombotic events (venous and arterial) and/or pregnancy morbidity.
- The presence of antiphospholipid antibodies (aPL) is a key diagnostic feature.
Purpose of the Study:
- To define the key characteristics of Antiphospholipid Syndrome (APS).
- To outline diagnostic criteria for APS.
- To differentiate between primary and secondary APS.
Main Methods:
- Review of clinical and laboratory diagnostic criteria for APS.
- Analysis of associations between APS and other autoimmune diseases, particularly SLE.
- Discussion of the systemic impact of APS.
Main Results:
- APS diagnosis requires clinical criteria (thrombosis or pregnancy morbidity) and laboratory confirmation of aPL.
- APS can occur independently (primary) or in conjunction with other autoimmune conditions (secondary), notably systemic lupus erythematosus (SLE).
- The condition affects nearly all organ systems.
Conclusions:
- Accurate diagnosis of APS relies on both clinical presentation and specific immunological tests, including lupus anticoagulant and aPL determinations.
- Understanding the distinction between primary and secondary APS is crucial for patient management.
- APS is a multisystem disorder with significant clinical implications.